AQP9 and metabolic dysfunction-associated steatohepatitis: Phytochemical modulation of AQP9 expression by nutraceutics counteracting excess hepatic lipid accumulation (Cataldo et al., 2017; Tesse et al., 2018) is also worthy of investigation in preventing or improving prognosis of NAFLD/NASH.